$ALGN
ALIGN TECHNOLOGY INC Stock $algn

$algn Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-Q Financial Statement

#000144530514001766 Filed on May 01, 2014

Income Statement

Concept	2014 Q1	2013 Q1
Revenue	$180.6M	$153.6M
YoY Change	17.62%	13.7%
Cost Of Revenue	$43.40M	$40.73M
YoY Change	6.54%	18.68%
Gross Profit	$137.3M	$112.8M
YoY Change	21.62%	12.0%
Gross Profit Margin	75.98%	73.48%
Selling, General & Admin	$111.2M	$72.63M
YoY Change	53.17%	16.71%
% of Gross Profit	81.05%	64.36%
Research & Development	$13.38M	$11.28M
YoY Change	18.6%	7.18%
% of Gross Profit	9.75%	10.0%
Depreciation & Amortization	$4.776M	$4.944M
YoY Change	-3.4%	26.77%
% of Gross Profit	3.48%	4.38%
Operating Expenses	$95.45M	$150.9M
YoY Change	-36.76%	107.44%
Operating Profit	$41.80M	-$38.08M
YoY Change	-209.79%	-235.95%
Interest Expense	$600.0K	$200.0K
YoY Change	200.0%	0.0%
% of Operating Profit	1.44%
Other Income/Expense, Net	$601.0K	-$988.0K
YoY Change	-160.83%	21.67%
Pretax Income	$42.41M	-$39.06M
YoY Change	-208.56%	-243.65%
Income Tax	$9.961M	$2.920M
% Of Pretax Income	23.49%
Net Earnings	$32.44M	-$41.98M
YoY Change	-177.28%	-300.07%
Net Earnings / Revenue	17.96%	-27.34%
Basic Earnings Per Share	$0.40	-$0.52
Diluted Earnings Per Share	$0.39	-$0.52
COMMON SHARES
Basic Shares Outstanding	81.12M shares	81.25M shares
Diluted Shares Outstanding	82.82M shares	81.25M shares

Balance Sheet

Concept	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$351.1M	$366.7M
YoY Change	-4.25%	52.56%
Cash & Equivalents	$167.5M	$328.7M
Short-Term Investments	$183.7M	$37.98M
Other Short-Term Assets	$43.70M	$36.50M
YoY Change	19.73%	-1.88%
Inventory	$15.84M	$15.44M
Prepaid Expenses
Receivables	$126.2M	$108.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$552.2M	$527.3M
YoY Change	4.71%	36.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$79.09M	$72.67M
YoY Change	8.84%	15.51%
Goodwill	$84.39M	$58.54M
YoY Change	44.15%	-56.9%
Intangibles		$25.43M
YoY Change		-47.97%
Long-Term Investments	$138.9M	$10.70M
YoY Change	1198.13%	-36.31%
Other Assets	$8.315M	$3.173M
YoY Change	162.05%	9.08%
Total Long-Term Assets	$333.5M	$198.9M
YoY Change	67.64%	-32.11%
TOTAL ASSETS
Total Short-Term Assets	$552.2M	$527.3M
Total Long-Term Assets	$333.5M	$198.9M
Total Assets	$885.6M	$726.2M
YoY Change	21.95%	7.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.51M	$19.75M
YoY Change	-6.29%	34.89%
Accrued Expenses	$71.35M	$64.64M
YoY Change	10.39%	-2.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$170.9M	$143.9M
YoY Change	18.77%	5.91%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$18.03M	$21.27M
YoY Change	-15.23%	83.6%
Total Long-Term Liabilities	$18.03M	$21.27M
YoY Change	-15.23%	83.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$170.9M	$143.9M
Total Long-Term Liabilities	$18.03M	$21.27M
Total Liabilities	$188.9M	$165.1M
YoY Change	14.39%	12.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.47M	-$133.4M
YoY Change	-52.42%	37.26%
Common Stock	$8.000K	$8.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$696.8M	$561.1M
YoY Change
Total Liabilities & Shareholders Equity	$885.6M	$726.2M
YoY Change	21.95%	8.32%

Cashflow Statement

Concept	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	$32.44M	-$41.98M
YoY Change	-177.28%	-300.07%
Depreciation, Depletion And Amortization	$4.776M	$4.944M
YoY Change	-3.4%	26.77%
Cash From Operating Activities	$17.99M	$10.42M
YoY Change	72.71%	41.15%
INVESTING ACTIVITIES
Capital Expenditures	$4.996M	$5.608M
YoY Change	-10.91%	-55.35%
Acquisitions
YoY Change
Other Investing Activities	$133.0K	-$1.079M
YoY Change	-112.33%
Cash From Investing Activities	-$99.35M	-$3.445M
YoY Change	2783.8%	-90.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$11.95M	-$10.83M
YoY Change	10.3%	41.46%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$21.06M	$15.42M
YoY Change	36.56%	7.92%
NET CHANGE
Cash From Operating Activities	$17.99M	$10.42M
Cash From Investing Activities	-$99.35M	-$3.445M
Cash From Financing Activities	$21.06M	$15.42M
Net Change In Cash	-$60.29M	$22.40M
YoY Change	-369.21%	-237.21%
FREE CASH FLOW
Cash From Operating Activities	$17.99M	$10.42M
Capital Expenditures	$4.996M	$5.608M
Free Cash Flow	$13.00M	$4.810M
YoY Change	170.21%	-192.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	18506000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17718000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	126183000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	113250000	USD
CY2014Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	408000	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1205000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	80345000	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	71349000	USD
CY2014Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	9851000	USD
CY2013Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	10100000	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1892000	USD
CY2014Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2085000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	294000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	442000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	729578000	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	759768000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9132000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6410000	USD
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2014Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2013Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	26320000	USD
CY2013Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	26300000	USD
CY2013Q4	us-gaap	Assets Assets	832147000	USD
CY2014Q1	us-gaap	Assets Assets	885641000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	544676000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	552177000	USD
CY2014Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	322606000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	229018000	USD
CY2013Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	127040000	USD
CY2014Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	183677000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	127040000	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	183677000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	101978000	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	138929000	USD
CY2014Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	138929000	USD
CY2013Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	101978000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	182766000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	242953000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	328745000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	306386000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	43029000	USD
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	32400000	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	13568000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	7739000	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	13568000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	7739000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1951000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-60187000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	22359000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80583000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81632000	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81632000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80583000	shares
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32592000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42035000	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	40731000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	43395000	USD
CY2013Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0175
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	931000	USD
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12769000	USD
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	81000000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	77275000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	22739000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	15766000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35400000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4944000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4776000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-37000	USD
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	106000	USD
CY2013Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.075
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2600000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2600000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2600000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2600000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53485000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53485000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23739000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22637000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30348000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29179000	USD
CY2014Q1	us-gaap	Goodwill Goodwill	84388000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	85362000	USD
CY2014Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	40693000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	112849000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	137251000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	42405000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39063000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9961000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2920000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1611000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	265000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13939000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10002000	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-15286000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-7941000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3083000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1476000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	320000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1870000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1790000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	586000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4555000	USD
CY2014Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6286000	USD
CY2014Q1	us-gaap	Inventory Net InventoryNet	15840000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	13968000	USD
CY2014Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5962000	USD
CY2013Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5172000	USD
CY2014Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3592000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4241000	USD
CY2014Q1	us-gaap	Liabilities Liabilities	188888000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	198177000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	885641000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	832147000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	175338000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	170855000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21061000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15423000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3445000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-99347000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-41983000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	32444000	USD
CY2014Q1	us-gaap	Noncurrent Assets NoncurrentAssets	79093000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10418000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17993000	USD
CY2013Q4	us-gaap	Noncurrent Assets NoncurrentAssets	75743000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-988000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	601000	USD
CY2014Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	95447000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	150924000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-38075000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	41804000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	29566000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1539000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4413000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7717000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8437000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	500000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6854000	USD
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7016000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8315000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8622000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	42000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-55000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	106000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	148000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-52000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18033000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	22839000	USD
CY2013Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	444000	USD
CY2014Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1977000	USD
CY2014Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	133000	USD
CY2013Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1079000	USD
CY2014Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2438000	USD
CY2013Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3141000	USD
CY2014Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4453000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3282000	USD
CY2014Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	157919000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4996000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5608000	USD
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11946000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13268000	USD
CY2013Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5000	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	43711000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	47465000	USD
CY2014Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	53137000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	4366000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	10564000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79093000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	75743000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13380000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11282000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95910000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63465000	USD
CY2014Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6230000	USD
CY2013Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6215000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	180646000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	153580000	USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52888000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	42281000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9132000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6410000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.467
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.423
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.002
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.002
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	783000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.96
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.97
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.17
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	30814000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	848000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1321000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.47
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	30755000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	846000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	15.46
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y2M12D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y2M12D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	28857000	USD
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y6M11D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M22D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y6M22D
CY2013Q1	algn	Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare	0.07
CY2013Q4	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	10488000	USD
CY2014Q1	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	11590000	USD
CY2013Q4	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	19258000	USD
CY2014Q1	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	19258000	USD
CY2014Q1	algn	Future Amortization Expense Thereafter FutureAmortizationExpenseThereafter	10286000	USD
CY2013Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3104000	USD
CY2013Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	3104000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	3048000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4050000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4129000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3048000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	709000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1184000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	653000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1263000	USD
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	472000	shares
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	633970000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	696753000	USD
CY2014Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	27900000	USD
CY2014Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of estimates</font></div><div style="line-height:120%;text-indent:16px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles ("GAAP") in the United States of America (“U.S.”) requires our management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, long-lived assets and goodwill, useful lives of intangible assets and property and equipment, stock-based compensation, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</font></div></div>
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1697000	shares
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81248000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82817000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81120000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81248000	shares
CY2013Q4	algn	Accrued Accounts Payable AccruedAccountsPayable	4053000	USD
CY2014Q1	algn	Accrued Accounts Payable AccruedAccountsPayable	5622000	USD
CY2013Q4	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	3893000	USD
CY2014Q1	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	4689000	USD
CY2013Q4	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	1733000	USD
CY2014Q1	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	1798000	USD
CY2014Q1	algn	Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare	0.09
CY2013	algn	Marketable Securities Weighted Average Remaining Maturity MarketableSecuritiesWeightedAverageRemainingMaturity	P10M
CY2014Q1	algn	Marketable Securities Weighted Average Remaining Maturity MarketableSecuritiesWeightedAverageRemainingMaturity	P11M
CY2014Q1	algn	Maturity Period Used To Classify Investments MaturityPeriodUsedToClassifyInvestments	P2Y
CY2014Q1	algn	Operating Leases Future Minimum Payments Due Remainder Of Period OperatingLeasesFutureMinimumPaymentsDueRemainderOfPeriod	6960000	USD
CY2014Q1	algn	Standard Product Warranty Time Period StandardProductWarrantyTimePeriod	P1Y
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001097149
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	81635404	shares
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	ALIGN TECHNOLOGY INC
CY2014Q1	dei	Trading Symbol TradingSymbol	ALGN

Files In Submission

Name	View Source	Status
0001445305-14-001766-index-headers.html	Edgar Link	pending
0001445305-14-001766-index.html	Edgar Link	pending
0001445305-14-001766.txt	Edgar Link	pending
0001445305-14-001766-xbrl.zip	Edgar Link	pending
algn-20140331.xml	Edgar Link	completed
algn-20140331.xsd	Edgar Link	pending
algn-20140331_cal.xml	Edgar Link	unprocessable
algn-20140331_def.xml	Edgar Link	unprocessable
algn-20140331_lab.xml	Edgar Link	unprocessable
algn-20140331_pre.xml	Edgar Link	unprocessable
algn-2014131xex311.htm	Edgar Link	pending
algn-2014131xex312.htm	Edgar Link	pending
algn-2014131xex321.htm	Edgar Link	pending
algn-2014331xq1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
utilizationgraphq12014a01.gif	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALGN
ALIGN TECHNOLOGY INC Stock $algn

2014 Q1 Form 10-Q Financial Statement

#000144530514001766 Filed on May 01, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN ALIGN TECHNOLOGY INC Stock $algn

2014 Q1 Form 10-Q Financial Statement

#000144530514001766 Filed on May 01, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN
ALIGN TECHNOLOGY INC Stock $algn